X-linked agammaglobulinemia (XLA):Phenotype, diagnosis, and therapeutic challenges around the world.

ABSTRACT:

Background

X-linked agammaglobulinemia is an inherited immunodeficiency recognized since 1952. In spite of seven decades of experience, there is still a limited understanding of regional differences in presentation and complications. This study was designed by the Primary Immunodeficiencies Committee of the World Allergy Organization to better understand regional needs, challenges and unique patient features.

Methods

A survey instrument was designed by the Primary Immunodeficiencies Committee of the World Allergy Organization to collect both structured and semi-structured data on X-linked agammaglobulinemia. The survey was sent to 54 centers around the world chosen on the basis of World Allergy Organization participation and/or registration in the European Society for Immuno

SUBMITTER: El-Sayed ZA 

PROVIDER: S-EPMC6439403 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature